40 million people living in the United States take statins to help reduce their cholesterol levels and risk of heart disease.But statins can also have a strong anti-inflammatory, anti-blood clotting, and antiviral effect, all of which may help limit complications associated with severe COVID-19.
That is why researchers are trying to figure out if statin use impacts COVID-19 outcomes.In a new study, a group of researchers, including cardiologists caring for hospitalized COVID-19 patients in New York, set out to compare patient outcomes between people who had used statins before hospitalization and those who had not.